So sánh phương pháp

	Bảng đánh giá kết quả mũi xoang - 22 (SNOT-22)	Bảng câu hỏi về chất lượng cuộc sống trong Viêm mũi kết mạc dị ứng
Lĩnh vực	Hô hấp học	Hô hấp học
Họ	Process / pipeline	Process / pipeline
Năm ra đời	2009	1996
Người khởi xướng	Claire Hopkins, King's College London	Elizabeth F. Juniper, McMaster University
Loại	Self-report questionnaire	Self-report questionnaire
Công trình gốc	Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology, 34(5), 447-454.	Juniper, E. F., Guyatt, G. H., Streiner, D. L., & King, D. R. (1996). Clinical validation and responsiveness of three scales developed to measure the effect of allergic rhinitis on quality of life. Journal of Clinical Epidemiology, 49(3), 339-347.
Tên gọi khác	SNOT-22, SNOT	RQLQ, Rhinoconjunctivitis QoL
Liên quan	5	5
Tóm tắt	The SNOT-22 is a 22-item disease-specific quality-of-life questionnaire designed to assess sino-nasal symptoms and their functional impact on patients with chronic rhinosinusitis, nasal polyposis, and allied conditions. Developed by Hopkins and colleagues at King's College London in 2009, it has become the most widely used instrument for measuring sino-nasal disease burden in clinical trials and rhinological practice. The SNOT-22 provides rapid, patient-centered assessment of both nasal-specific symptoms (congestion, drainage, sneezing) and general health impacts (sleep, headache, concentration).	The RQLQ is a 28-item disease-specific quality-of-life instrument developed by Juniper and colleagues at McMaster University in 1996 to assess the impact of allergic rhinitis and allergic conjunctivitis on daily functioning. It captures symptom burden and activity limitation across seven domains: sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, activity limitation, and emotional function. The RQLQ is the preferred outcome measure in allergic rhinitis clinical trials and is widely used in allergy and immunology practice to track treatment response.